124 related articles for article (PubMed ID: 31558691)
21. Protein phosphatase 4 catalytic subunit is overexpressed in glioma and promotes glioma cell proliferation and invasion.
Li M; Li X; Xu S; Xue P; Li Q; Lu Q; Jia Q; Zhang L; Li X; Li X
Tumour Biol; 2016 Sep; 37(9):11893-11901. PubMed ID: 27059736
[TBL] [Abstract][Full Text] [Related]
22. NLRP3 in human glioma is correlated with increased WHO grade, and regulates cellular proliferation, apoptosis and metastasis via epithelial-mesenchymal transition and the PTEN/AKT signaling pathway.
Yin XF; Zhang Q; Chen ZY; Wang HF; Li X; Wang HX; Li HX; Kang CM; Chu S; Li KF; Li Y; Qiu YR
Int J Oncol; 2018 Sep; 53(3):973-986. PubMed ID: 30015880
[TBL] [Abstract][Full Text] [Related]
23. HOXA10‑AS: A novel oncogenic long non‑coding RNA in glioma.
Dong CY; Cui J; Li DH; Li Q; Hong XY
Oncol Rep; 2018 Nov; 40(5):2573-2583. PubMed ID: 30132568
[TBL] [Abstract][Full Text] [Related]
24. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo.
Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG
Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024
[TBL] [Abstract][Full Text] [Related]
25. Lentivirus mediated γ-interferon-inducible lysosomal thiol reductase (GILT) knockdown suppresses human glioma U373MG cell proliferation.
Chen S; Wang Q; Shao X; Di G; Dai Y; Jiang X; Cheng L
Biochem Biophys Res Commun; 2019 Jan; 509(1):182-187. PubMed ID: 30587343
[TBL] [Abstract][Full Text] [Related]
26. UHRF2 mRNA expression is low in malignant glioma but silencing inhibits the growth of U251 glioma cells in vitro.
Wu TF; Zhang W; Su ZP; Chen SS; Chen GL; Wei YX; Sun T; Xie XS; Li B; Zhou YX; Du ZW
Asian Pac J Cancer Prev; 2012; 13(10):5137-42. PubMed ID: 23244124
[TBL] [Abstract][Full Text] [Related]
27. Low expression of microRNA-320b correlates with tumorigenesis and unfavorable prognosis in glioma.
Lv QL; Du H; Liu YL; Huang YT; Wang GH; Zhang X; Chen SH; Zhou HH
Oncol Rep; 2017 Aug; 38(2):959-966. PubMed ID: 28656255
[TBL] [Abstract][Full Text] [Related]
28. DNA vaccines to target the cancer testis antigen PASD1 in human multiple myeloma.
Joseph-Pietras D; Gao Y; Zojer N; Ait-Tahar K; Banham AH; Pulford K; Rice J; Savelyeva N; Sahota SS
Leukemia; 2010 Nov; 24(11):1951-9. PubMed ID: 20861911
[TBL] [Abstract][Full Text] [Related]
29. Myocyte enhancer factor 2D promotes tumorigenicity in malignant glioma cells.
Zhao Y; Li Y; Ma Y; Wang S; Cheng J; Yang T; Sun Z; Kuang Y; Huang H; Fan K; Gu J
Tumour Biol; 2016 Jan; 37(1):601-10. PubMed ID: 26234765
[TBL] [Abstract][Full Text] [Related]
30. MiR-210 up-regulation inhibits proliferation and induces apoptosis in glioma cells by targeting SIN3A.
Shang C; Hong Y; Guo Y; Liu YH; Xue YX
Med Sci Monit; 2014 Dec; 20():2571-7. PubMed ID: 25481483
[TBL] [Abstract][Full Text] [Related]
31. Over-expression of the long non-coding RNA HOTTIP inhibits glioma cell growth by BRE.
Xu LM; Chen L; Li F; Zhang R; Li ZY; Chen FF; Jiang XD
J Exp Clin Cancer Res; 2016 Oct; 35(1):162. PubMed ID: 27733185
[TBL] [Abstract][Full Text] [Related]
32. Decreased expression of SOX9 indicates a better prognosis and inhibits the growth of glioma cells by inducing cell cycle arrest.
Gao J; Zhang JY; Li YH; Ren F
Int J Clin Exp Pathol; 2015; 8(9):10130-8. PubMed ID: 26617720
[TBL] [Abstract][Full Text] [Related]
33. Upregulation of long noncoding RNA zinc finger antisense 1 enhances epithelial-mesenchymal transition in vitro and predicts poor prognosis in glioma.
Lv QL; Chen SH; Zhang X; Sun B; Hu L; Qu Q; Huang YT; Wang GH; Liu YL; Zhang YY; Zhou HH
Tumour Biol; 2017 Mar; 39(3):1010428317695022. PubMed ID: 28349823
[TBL] [Abstract][Full Text] [Related]
34. Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.
Meng Q; Luo G; Liu B; Sun Y; Yan Z
Neoplasma; 2018; 65(4):604-609. PubMed ID: 30064232
[TBL] [Abstract][Full Text] [Related]
35. Bromodomain PHD‑finger transcription factor promotes glioma progression and indicates poor prognosis.
Pan Y; Yuan F; Li Y; Wang G; Lin Z; Chen L
Oncol Rep; 2019 Jan; 41(1):246-256. PubMed ID: 30542695
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of iASPP-SV in glioma is associated with poor prognosis by promoting cell viability and antagonizing apoptosis.
Liu X; Kang J; Liu F; Wen S; Zeng X; Liu K; Luo Y; Ji X; Zhao S
Tumour Biol; 2016 May; 37(5):6323-30. PubMed ID: 26628298
[TBL] [Abstract][Full Text] [Related]
37. Interference of Notch 2 inhibits the progression of gliomas and induces cell apoptosis by induction of the cell cycle at the G0/G1 phase.
Yu HP; Qi ST; Feng WF; Zhang GZ; Zhang HP; Tian JJ
Mol Med Rep; 2015 Jan; 11(1):734-8. PubMed ID: 25338527
[TBL] [Abstract][Full Text] [Related]
38. Downregulation of miR-95-3p inhibits proliferation, and invasion promoting apoptosis of glioma cells by targeting CELF2.
Fan B; Jiao BH; Fan FS; Lu SK; Song J; Guo CY; Yang JK; Yang L
Int J Oncol; 2015 Sep; 47(3):1025-33. PubMed ID: 26165303
[TBL] [Abstract][Full Text] [Related]
39. B-cell CLL/lymphoma 3 promotes glioma cell proliferation and inhibits apoptosis through the oncogenic STAT3 pathway.
Wu J; Li L; Jiang G; Zhan H; Wang N
Int J Oncol; 2016 Dec; 49(6):2471-2479. PubMed ID: 27748795
[TBL] [Abstract][Full Text] [Related]
40. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]